🧬 Receptor activity
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| Amine oxidase [flavin-containing] A (MAOA) | Inhibitor | 8.3 Ki | DRUGCENTRAL | TargetAmine oxidase [flavin-containing] A (MAOA) ActionInhibitor Affinity8.3 Ki SourceDRUGCENTRAL |
| 5-hydroxytryptamine receptor 1A (HTR1A) | — | 5.3 Kd | DRUGCENTRAL | Target5-hydroxytryptamine receptor 1A (HTR1A) Action— Affinity5.3 Kd SourceDRUGCENTRAL |
| Amine oxidase [flavin-containing] A (Maoa) | — | 8.3 Ki | DRUGCENTRAL | TargetAmine oxidase [flavin-containing] A (Maoa) Action— Affinity8.3 Ki SourceDRUGCENTRAL |
| Amine oxidase [flavin-containing] B (MAOB) | — | 5.97 Ki | DRUGCENTRAL | TargetAmine oxidase [flavin-containing] B (MAOB) Action— Affinity5.97 Ki SourceDRUGCENTRAL |
| Potassium voltage-gated channel subfamily H member 2 (KCNH2) | — | 4.1 IC50 | DRUGCENTRAL | TargetPotassium voltage-gated channel subfamily H member 2 (KCNH2) Action— Affinity4.1 IC50 SourceDRUGCENTRAL |
External links
PubChem 4235 ↗CAS 71320-77-9 ↗ChEBI CHEBI:83531 ↗ChEMBL CHEMBL86304 ↗KEGG D02561 ↗DrugBank DB01171 ↗ChemSpider ↗ChEBI/ChEMBL ↗Guide to Pharmacology ↗NIH ↗NIH ↗NIH ↗DrugBank ↗ChEBI/ChEMBL ↗CAS 108375-13-9 ↗CAS 63378-13-2 ↗PsychonautWiki ↗Erowid ↗Experience reports (PiHKAL) ↗Experience reports (TiHKAL) ↗
Source: DrugCentral — Moclobemide ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.